4D Molecular Therapeutics, Inc., a late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and the United States. The company's lead product candidate is...
5 insider purchases on record · latest filing 2023-05-11.
Insiders have also filed 91 sale transactions at FDMT.